It was a huge pleasure to catch up with our esteemed Editorial Board member, Cynthia Matossian (Matossian Eye Associates, Hopewell and Hamilton, NJ, USA), as she talked us through her AAO presentation on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
- What is the rationale for the use of dexamethasone intraocular suspension 9% at the conclusion of cataract surgery? (00:16)
- What were the aims and design of the study you presented at AAO? (01:50)
- What did the findings of the study teach us about the use of dexamethasone intraocular suspension 9%? (03:16)
- How are these findings likely to impact on future clinical practice? (04:06)
- Which patients are likely to benefit most from this treatment approach? (05:55)
Speaker Disclosure: Dr Cynthia Matossian is a consultant to EyePoint.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AAO 2020.
Share this Video
Related Videos In Cataract Surgery
Eric Donnenfeld, Hawaiian Eye and Retina 2021: Next-generation Extended Depth of Focus Intraocular Lenses
It was a pleasure to speak with Eric Donnenfeld (Ophthalmic Consultants of Long Island, NY, USA) about advantages and limitations of new extended depth of focus intraocular lenses and the future of this technology. Questions What factors need to be considered when selecting an extended depth of focus (EDOF) intraocular lens (IOL) for a patient […]
Eric Donnenfeld, Hawaiian Eye and Retina 2021: Extended Depth of Focus Intraocular Lenses Following Cataract Surgery
We were delighted to speak to Eric Donnenfeld (Ophthalmic Consultants of Long Island, NY, USA) about limitations of multifocal intraocular lenses (IOLs) following cataract surgery, and how extended depth of focus IOLs have overcome these limitations. Questions What are the limitations of multifocal intraocular lenses (IOLs) following cataract surgery? (00:16) How have extended depth of […]
Jorge L Alió, EGS 2020 – Innovations in Premium IOLs
We caught up with Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) to find out the most promising recent advances in premium IOLs. Questions Could you give us a brief overview of your experience with premium IOLs? (0:05) What are the most promising recent advances and what issues with premium IOLs remain to […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!